NCT07068516 2025-07-16
Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer
Zhejiang Cancer Hospital
Phase 3 Not yet recruiting
Zhejiang Cancer Hospital
The First Affiliated Hospital with Nanjing Medical University